|
 |
Huntingtons Disease > Anti-tumor Drug
The following information is about Anti-tumor Drug.
Anti-tumor Drug Defined
A drug that is capable of either stopping or slowing the abnormal growth of tissue. Because the presence of tumors is one of the primary characteristics of cancer, anti-tumor drugs are often used to treat cancer.
This definition is in context to Huntingtons Disease. See more contextual defintions for Anti-tumor Drug.
VioQuest Pharmaceuticals issued new U.S. patent for Lenocta
Published August 26, 2008, 4:12 pm, News-Medical-Net
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment ...
Morphotek,(R) Inc. Expands Its Phase II Trial Site Selections in the European Union
Published August 26, 2008, 8:34 am, Centre Daily Times
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced that it has opened clinical sites in the European Union (EU) as part of the company's MORAb-009 Phase II study. The study is evaluating MORAb-009, a monoclonal antibody to mesothelin, as a first-line treatment for patients with pancreatic cancer. The randomized, controlled, double-blinded trial will compare ...
Morphotek,(R) Inc. Expands Its Phase II Trial Site Selections in the European Union
Published August 26, 2008, 6:00 am, Business Wire via Yahoo! Finance
EXTON, Pa.----Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, today announced that it has opened clinical sites in the European Union as part of the company's MORAb-009 Phase II study.
VioQuest Pharmaceuticals Announces Issuance of New U.S. Patent for Lenocta(TM)
Published August 26, 2008, 4:30 am, Business Wire via Yahoo! Finance
BASKING RIDGE, N.J.----VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta™ . U.S.
Chelsea Therapeutics Receives Fast Track Designation for Droxidopa for Symptomatic Neurogenic Orthostatic Hypotension
Published August 26, 2008, 4:30 am, PrimeNewswire via Yahoo! Finance
CHARLOTTE, N.C., Aug. 26, 2008 -- Chelsea Therapeutics International, Ltd. announced that the U.S. Food and Drug Administration has granted Fast Track designation to Droxidopa for the treatment of symptomatic neurogenic orthostatic hypotension .
Anti-tumor Effects Are Enhanced By Inhibiting Two Pathways Rather Than One
Published August 24, 2008, 6:19 pm, Science Daily
Two independent research groups have found that simultaneous inhibition of two signaling pathways -- mTOR and MAPK signaling pathways -- results in substantially enhanced antitumor effects when compared with inhibition of either pathway alone in mouse models of prostate and breast cancer.
Inhibiting 2 Pathways Rather Than 1 Enhances Anti-Tumor Effects
Published August 24, 2008, 4:13 am, Medical News Today
Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer.
NovaRx Initiates Pivotal Phase III Clinical Trial In Lung Cancer Patients
Published August 22, 2008, 5:14 am, Medical News Today
NovaRx Corporation announced that the company initiated its pivotal Phase III clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC). The first patient enrolled in the study was treated by Dr. Lyudmila Bazhenova the trial's principal investigator at the University of California, San Diego School of Medicine.
Are you looking for additional Huntingtons Disease > Anti-tumor Drug news? Try our new "Anti-tumor Drug News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Anti-tumor Drug. If you would like to find related tags we recommend Tag Patterns > Anti-tumor Drug
Off-site Anti-tumor Drug Research Links
If you still need additional information on Anti-tumor Drug then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Anti-tumor Drug
- Alexa > Anti-tumor Drug
- Anti-Aging Revolution > Anti-tumor Drug
- DMOZ > Anti-tumor Drug
- Feeds Filtered > Anti-tumor Drug
- Google > Anti-tumor Drug
- News Meme > Anti-tumor Drug
- Nuah: News > Anti-tumor Drug
- The Feed Directory > Anti-tumor Drug
- OBP > Anti-tumor Drug
- Open Tag Directory > Anti-tumor Drug
- Podzy > Anti-tumor Drug
- Yahoo > Anti-tumor Drug
Huntingtons Disease Topics
Everything you need to know about Huntingtons Disease
Huntingtons Disease
If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.